Active, Not Recruiting
Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
NCT05845671
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- City of Hope Cancer Center Duarte, California, United States
- Outpatient CTRC Aurora, Colorado, United States
- University of Colorado Hospital Aurora, Colorado, United States
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States